News
21hon MSN
Find insight on Regis Healthcare, CSPC Pharmaceutical and more in the latest Market Talks covering the health care sector.
20hon MSN
Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...
Astrazeneca (AZN) closed the most recent trading day at $73.55, moving -1.17% from the previous trading session. The stock's ...
Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...
This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Cambridge headquartered global pharmaceutical company AstraZeneca took its spending on China plays in the last month to ...
An AI approach developed by researchers from the University of Sheffield and AstraZeneca, could make it easier to design ...
Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...
AstraZeneca PLC closed 19.20% below its 52-week high of £133.88, which the company achieved on September 3rd.
ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILINGPoster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...
Scientists from the University of Sheffield and AstraZeneca have created an AI approach that could make designing proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results